Colony Bankcorp, Inc.
NYSE:CBANBanks - Regional
+$0.01 today
- Market cap
- $542.11M
- Beta
- 0.55
- P/E (TTM)
- 14.6
- EPS (TTM)
- $1.41
- Dividend yield
- 2.29%
Volume 0.25M
Average 0.31M
CBAN Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Colony Bankcorp, Inc.NYSE: CBAN
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses remains negative
Q1 FY2026 other income / expenses was $0, compared with $0 a year earlier. Trailing-twelve-month other income / expenses was -$1.65M.
Context
- Other income / expenses amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Other income / expenses increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$412.5K.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Income / Expenses vs competitors
How CBAN compares with its peers on the latest reported figures
- CBAN's LTM Mar 2026 other income / expenses of -$1.65M is the 10th highest of the 11 companies compared; the peer median is $0.
- Other income / expenses amounts to 0.8% of revenue for CBAN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.45M | — | — | 2.6% | |
| LTM Mar 2026 | $1.99M | — | — | 1.7% | |
| LTM Mar 2026 | $284K | — | — | 0.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | -$1.65M | — | — | 0.8% | |
| LTM Mar 2026 | -$3.62M | — | — | 1.6% | |
| Peer median (excluding CBAN) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CBAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 106.88M | 126.56M | 160.55M | 176.62M | 186.11M |
| Cost of Revenue | 5.1M | 14.24M | 50.27M | 64.22M | 62.55M |
| Gross Profit | 101.78M | 112.33M | 110.28M | 112.4M | 123.56M |
| Gross Margin | 95.2% | 88.8% | 68.7% | 63.6% | 66.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.25M | 56.47M | 52.72M | 53.78M | 3.51M |
| Operating Expenses | 78.63M | 89.48M | 83.07M | 82.83M | 88.42M |
| Depreciation & Amortization | 8.63M | 11.63M | 8.7M | 8.13M | 93K |
| EBITDA | 31.78M | 34.48M | 35.92M | 37.7M | 35.14M |
| EBITDA Margin | 29.7% | 27.2% | 22.4% | 21.3% | 18.9% |
| Operating Income | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Operating Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Interest Income | 70.59M | 91.49M | 124.92M | 137.24M | 149.95M |
| Interest Expense | 4.4M | 10.87M | 46.67M | 61.17M | 58.05M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Pre-Tax Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Income Tax Expense | 4.5M | 3.31M | 5.47M | 5.7M | 6.88M |
| Net Income | 18.66M | 19.54M | 21.75M | 23.87M | 28.25M |
| Net Margin | 17.5% | 15.4% | 13.5% | 13.5% | 15.2% |
| EPS (Basic) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| EPS (Diluted) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| Weighted Avg Shares | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
| Weighted Avg Shares (Diluted) | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
Colony Bankcorp, Inc.
NYSE:CBAN
Intrinsic Alpha fair value
Locked
Current Price
$19.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.